Etomidate has recently been proposed as a hypnotic for high-fidelity fMRI in mice. It largely preserves cerebrovascular autoregulation and basal perfusion, thus providing a large window for hemodynamic-based fMRI readouts. However, commercially available formulations of etomidate come at low concentration and are suitable only for intravenous infusion, hence resulting in large infusion volumes and difficult procedures in small rodents. Here, we demonstrate that fMRI-compatible anaesthesia can be readily achieved upon subcutaneous administration of etomidate formulated as aqueous solution. We further propose to substitute etomidate with its short-acting analogue cyclopropyl-methoxycarbonyl metomidate to avert long recovery times due to subcutaneous depot formation.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords